-
- Access >
- |
-
Health Professionals
-
About CupPrint®
Cancer of Unknown Primary (CUP) - a histologically confirmed metastasis with no identifiable primary site- is the fourth most common cause of cancer mortality and one of 10 most common cancer types world-wide. However, CUP is still a rather poorly understood phenomenon. The significant impact of the disease, combined with the poor prognosis of patients and the inability of conventional pathology and imaging techniques to identify a primary tumor in most CUP cases fuels the need for innovative diagnostic tools.
CupPrint® can offer valuable information to assist doctors in making important diagnosis and treatment decisions for their patients.
* CupPrint® is based on a license to the TUO database of AviaraDx inc*. CupPrint® is a service from Agendia, Slotervaart Hospital, Amsterdam, Holland. Distributed and commercialized in Spain by Ferrer inCode
Ferrer inCode | Diagonal, 549 5ª floor, E-08029 Barcelona | Phone. +34 93 600 37 00 | Fax: +34 93 490 70 78


